Velentium, a Houston-based engineering leader in medical device design and manufacturing, has secured a significant $15 million investment from Trinity Capital Inc. This strategic partnership fuels Velentium’s mission to deliver innovative and life-saving medical technologies.
Velentium’s expertise spans across the entire medical device lifecycle, from concept to production. Their team offers a unique blend of engineering prowess, software development, cybersecurity knowledge, and mobile/cloud solutions. This comprehensive approach empowers them to collaborate with global clients and bring cutting-edge medical devices to market.
“We are impressed with Velentium’s ability to provide a one-stop shop for medical device development,” said Ryan Kaeding, Managing Director of Life Sciences at Trinity Capital. “Their commitment to innovation and strong client partnerships position them for significant growth, and we’re excited to be a part of their journey.”
This investment comes at a pivotal time for Velentium. The company recently expanded its footprint with a new 50,000 square foot headquarters equipped with state-of-the-art cleanrooms. This enhanced infrastructure significantly bolsters their contract manufacturing capabilities.
“Partnering with Trinity Capital empowers us to accelerate our growth and further our mission of creating safer, more secure, and user-friendly medical devices,” said Dan Purvis, CEO of Velentium. “This collaboration allows us to continue transforming lives for the better.”
Velentium: A Beacon of Innovation in Medical Technology
Velentium’s dedication to end-to-end medical device development is a breath of fresh air in the healthcare industry. Their ability to offer a comprehensive solution, from design inception to manufacturing, streamlines the process and fosters collaboration. This investment from Trinity Capital is a testament to Velentium’s potential to revolutionize the medical device landscape and improve patient outcomes worldwide.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
